(Press-News.org) CAMBRIDGE, Mass., and SINGAPORE, Nov 18, 2025 – Apriori Bio, a Flagship Pioneering company focused on developing prospective, variant-resilient vaccines, and the Agency for Science, Technology and Research Infectious Diseases Labs (A*STAR IDL) announced a strategic research partnership to co-develop and evaluate next generation self-amplifying RNA (saRNA) vaccines targeting seasonal and pandemic influenza. The collaboration brings together Apriori’s Octavia™ platform for intelligent, prospective antigen design with A*STAR IDL’s saRNA delivery technology, and will initially focus on improved H5 influenza vaccines that anticipate infection in humans.
“This collaboration is an important step for Apriori as we unite complementary strengths in vaccine design and delivery to drive lasting immunity against one of the world’s most challenging viruses,” said Craig Williams, MBA, Chief Executive Officer of Apriori Bio and CEO-Partner at Flagship Pioneering. “Apriori has redefined what’s possible in vaccine development by harnessing the power of AI to predict viral evolution and protect people against pathogens that outpace traditional approaches, such as influenza. Together, with A*STAR IDL’s next generation RNA delivery capabilities, we aim to change the standard of protection for patients worldwide.”
Professor Lisa Ng, Executive Director of A*STAR IDL, said, “This collaboration reflects our shared commitment to translating research into real-world impact. By combining A*STAR IDL’s strengths in RNA and infectious disease expertise with Apriori’s AI-guided antigen design, we aim to accelerate vaccine development and strengthen preparedness for future outbreaks in Singapore and globally.”
Harry Kleanthous, Ph.D., Chief Scientific Officer of Apriori Bio, added, “Today’s vaccines against H5 influenza have shown limitations in achieving both robust single-dose immunity and breadth of protection against emerging viral variants. saRNA offers a compelling solution to deliver durable protection from a single dose, while Apriori’s Octavia™-generated antigen sequence would provide enhanced coverage. By addressing both of these critical unmet needs, we aim to develop the first anticipatory H5 vaccine to build a healthier future.”
Ms Irene Cheong, Assistant Chief Executive of A*STAR Innovation and Enterprise, added, “This partnership between A*STAR and Apriori Bio brings together complementary expertise in RNA and vaccine science that can better protect populations and strengthen global health security. A*STAR is excited to partner with another Flagship portfolio company with cutting-edge technologies to advance novel solutions for human health.”
The collaboration takes place under Flagship Pioneering’s ongoing institutional partnership with A*STAR, which aims to jointly advance breakthrough solutions for the advancement of human health, as well as to advance Singapore’s position as a global hub for biotechnological innovations.
– END –
About Apriori Bio
Apriori Bio is ushering in a new era of AI-enabled vaccine design to improve global health outcomes. Our pioneering approach centers on a unique technology platform, Octavia™, that predicts viral evolution, delivers improved vaccines that elicit ideal immune responses, and assesses how well they will perform before entering clinical trials. Apriori was founded in 2020 by Flagship Pioneering. For more information, visit www.aprioribio.com or follow us on LinkedIn and X.
About A*STAR IDL
A*STAR Infectious Diseases Labs (A*STAR IDL) was established in April 2021 with a mission to be a leading research institute of infectious diseases in antimicrobial resistance, respiratory and vector-borne diseases. A*STAR IDL brings together infectious diseases expertise from across multiple disciplines to drive cutting edge translational infectious diseases research to contribute to Singapore’s national preparedness and defence against the threat of emerging infections. Building upon a robust foundation of our strong biomedical research capabilities and complemented by our globally connected scientific network, A*STAR IDL aims to focus on innovative technologies in infectious disease detection, intervention and prevention with a pathway to impact on health and economic outcomes. For more information, visit https://www.a-star.edu.sg/idlabs or follow us on LinkedIn, Facebook and Instagram.
Apriori Media Contact
press@aprioribio.com
A*STAR Media Contact
Aileen Tan
Manager, Corporate Communications
Mobile: +65 9186 6450
Email: aileen_tan@hq.a-star.edu.sg
END
The Notre-Dame Cathedral in Lausanne was built between 1170 and 1235 and is the largest Gothic church in Switzerland. Over time, this imposing building has been altered, extended and restored on multiple occasions. The nearly 80-metre-tall lantern tower, for example, has undergone several redesigns over the years, the most recent of which took place at the end of the 19th century during an extensive restoration. The stone used to build this cathedral, and many other monuments in the Swiss plateau, is particularly susceptible to a variety of degradation mechanisms, all of which are enabled by the presence of water (such ...
Researchers at the University of Tokyo developed an experimental method to induce a strong physiological response linked to psychological pressure by making participants aim for a streak of success in a task. Their findings suggest this approach reproduces pressurelike conditions in a laboratory setting more effectively than traditional methods, affording easier access to the study of this state. That in turn could open up research into how pressure influences human performance in physical and intellectual tasks.
Whether in an exam hall or on the field, to “crack” under pressure is a common trope. But what’s the reality behind this idea? It’s easy to assume ...
Children have 20 milk teeth, 10 in each jaw. This set of teeth is important for chewing and speaking, and helps to keep space open for the subsequent set of 32 permanent teeth. Milk teeth begin to develop in the womb around the sixth week of gestation, and gradually come out ('erupt') between six months and three years after birth. However, there is considerable variation in this timing, due to genetics, geography, and an infant's overall health and nutritional status. Now, researchers from the US have shown for the first time that another factor can speed up the timing of teeth eruption: maternal ...
Nigella sativa (black cumin), the spice that boosts the flavor of curries like korma and paneer also has another use: its seeds have long been used as a medicinal plant in traditional medicine for their antioxidant and anti-inflammatory effects. Now, a clinical trial led by Osaka Metropolitan University suggests that they also have anti-obesity benefits.
To investigate these effects, a team led by Associate Professor Akiko Kojima-Yuasa of the Graduate School of Human Life and Ecology used cellular experiments and human clinical trials.
In ...
A research team in South Korea has developed a novel gasket technology that enhances both the safety and efficiency of polymer electrolyte membrane fuel cells (PEMFCs) and water electrolyzers (PEMWEs, AEMWEs)—core devices for hydrogen production and utilization—by simultaneously improving mechanical strength and gas-tight sealing.
Dr. Keun-Hwan Oh and his colleagues at the Korea Research Institute of Chemical Technology (KRICT) have successfully applied functionalized two-dimensional boron nitride nanoflakes (BNNFs) to silicone and ethylene-propylene-diene monomer (EPDM)-based sealing gaskets. The newly developed nanocomposite gasket demonstrates excellent ...
WASHINGTON, D.C. — [November 18, 2025] —Nearly half of U.S. adults (47%) are worried they won’t be able to afford necessary healthcare in the coming year, the highest level of concern recorded since West Health and Gallup began tracking in 2021. The share of Americans reporting that they or someone in their household were not able to pay for prescription medications in the past three months has reached a record high of 20%, or one in five Americans.
These trends are clear: millions of Americans are facing growing challenges ...
Vaccination rates are falling in many communities due to widespread misinformation and previously eliminated or controlled illnesses like measles are surging across the United States and Canada.
Researchers at the University of Waterloo have developed a new approach that could help public health officials predict where outbreaks might occur. By analyzing social media posts, the method identifies early signs of increasing vaccine skepticism — a warning signal that could emerge before any disease begins to spread.
“In nature, we have contagious ...
The rapid development of humanoid robots necessitates environmental perception for autonomous locomotion and dexterous manipulation. As one of the most fundamental perceptual modalities, tactile sensing provides critical physical feedback during contact-rich interactions. However, this sensing capability introduces a fundamental trade-off between compliance in physical interactions and high-fidelity response to mechanical stimuli.
The biomechanical intelligence of human fingertips offers a compelling paradigm ...
A University of Sydney-led study published today has found 42 percent of Australian adults — more than eight million people — experienced a traumatic event as children. Those affected have a 50 percent higher risk of developing a mental health or substance use disorder than the wider population, the research found. They are more likely to experience anxiety, depression or panic disorder later in life, with more than one in ten projected to attempt suicide.
The findings highlight a need for urgent investment in trauma-informed support to better protect children and prevent lifelong mental health impacts, the authors say.
Led by Dr Lucy Grummitt and Associate ...
A world’s most comprehensive meta-analysis in depression and mortality, led by the Department of Psychiatry at the School of Clinical Medicine, LKS Faculty of Medicine at the University of Hong Kong (HKUMed), has found that people with depression have twice the risk of death than those without depression, and a nearly 10-fold increased risk of suicide. However, timely and effective treatment can significantly reduce these risks and improve survival rates. This study analysed data from 268 cohort studies, covering over 10 million people living with depression and nearly 2.8 billion controls, making it the largest research of its kind to date. The ...
